Circulating Free DNA and Its Emerging Role in Autoimmune Diseases
Open Access
- 20 February 2021
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (2) , 151
Abstract
Liquid biopsies can be used to analyse tissue-derived information, including cell-free DNA (cfDNA), circulating rare cells, and circulating extracellular vesicles in the blood or other bodily fluids, representing a new way to guide therapeutic decisions in cancer. Among the new challenges of liquid biopsy, we found clinical application in nontumour pathologies, including autoimmune diseases. Since the discovery of the presence of high levels of cfDNA in patients with systemic lupus erythaematosus (SLE) in the 1960s, cfDNA research in autoimmune diseases has mainly focused on the overall quantification of cfDNA and its association with disease activity. However, with technological advancements and the increasing understanding of the role of DNA sensing receptors in inflammation and autoimmunity, interest in cfDNA and autoimmune diseases has not expanded until recently. In this review, we provide an overview of the basic biology of cfDNA in the context of autoimmune diseases as a biomarker of disease activity, progression, and prediction of the treatment response. We discuss and integrate available information about these important aspects.Keywords
This publication has 118 references indexed in Scilit:
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- TLR9 is important for protection against intestinal damage and for intestinal repairScientific Reports, 2012
- The Inhibition of Anti-DNA Binding to DNA by Nucleic Acid Binding PolymersPLOS ONE, 2012
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during ApoptosisImmunity, 2012
- Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in miceHepatology, 2011
- Serum DNA Motifs Predict Disease and Clinical Status in Multiple SclerosisThe Journal of Molecular Diagnostics, 2010
- Methylation patterns of cell-free plasma DNA in relapsing–remitting multiple sclerosisJournal of the Neurological Sciences, 2010
- Urinary Biomarkers in Lupus NephritisClinical Reviews in Allergy & Immunology, 2010
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Defining the clinical course of multiple sclerosisNeurology, 1996